EXHIBIT 10.7 VOTING AGREEMENT VOTING AGREEMENT, dated as of October 24, 1998, between Watson Pharmaceuticals, Inc., a Nevada corporation ("Parent"), and William I. Higuchi (the "Stockholder"). WHEREAS, Parent and Theratech, Inc., a Delaware...Voting Agreement • November 25th, 1998 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
ARTICLE 1 AMENDMENTSCredit Agreement • March 16th, 1998 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • California
1 EXHIBIT 99.1 AGREEMENT AND PLAN OF MERGER AMONG WATSON PHARMACEUTICALS, INC. WS ACQUISITION CORP.Merger Agreement • May 31st, 2000 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
EXHIBIT 10.1 ASSET PURCHASE AGREEMENT THIS ASSET PURCHASE AGREEMENT (this "Asset Purchase Agreement") is made and entered into September 18, 1998 (the "Effective Date") by and between G.D. Searle & Co., a Delaware corporation and Watson Laboratories...Asset Purchase Agreement • December 3rd, 1998 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • Illinois
Recitals: --------Lease • March 30th, 2001 • Watson Pharmaceuticals Inc • Pharmaceutical preparations
Exhibit 10.15 AMENDED AND RESTATED CREDIT AGREEMENT Dated as of August 28, 2000Credit Agreement • March 30th, 2001 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • New York
ARTICLE 1 AMENDMENTCredit Agreement • March 30th, 2000 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • California
1 EXHIBIT 10.1 CREDIT AGREEMENT Dated as of July 5, 2000Credit Agreement • July 14th, 2000 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • New York
Agreement ---------Stock Option Agreement • January 21st, 1999 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
SUPPLY AGREEMENT ----------------Supply Agreement • December 3rd, 1998 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • Illinois
1 Exhibit 10.2 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (the "Agreement") dated as of _______ ___, 1996 by and between Terry L. Johnson ("Employee"), Oclassen Pharmaceuticals, Inc., a Delaware corporation ("Company") and Watson Pharmaceuticals,...Employment Agreement • November 18th, 1996 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • California
Exhibit 10.7 STOCK OPTION AGREEMENT ---------------------- THIS STOCK OPTION AGREEMENT ("Agreement") is made as of this 25th day of February, 1995 between ROYCE LABORATORIES, INC., a Florida corporation ("Company"), and MAJOR PHARMACEUTICALS, INC., a...Stock Option Agreement • February 21st, 1997 • Watson Pharmaceuticals Inc • Pharmaceutical preparations
1 EXHIBIT 10.4 AGREEMENT REGARDING PARTNERSHIP TERMINATION This Agreement ("Agreement") is entered into as of June 30, 1997, by and among Watson Laboratories, Inc., a Nevada corporation ("Watson"), Circa Pharmaceuticals, Inc., a New York corporation...Partnership Agreement • July 15th, 1997 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • New York
EXHIBIT 10.27(A) AMENDMENT TO STOCK PURCHASE AGREEMENT THIS AMENDMENT (the "AMENDMENT") is made as of November 26, 1997, among HOECHST MARION ROUSSEL, INC., a Delaware corporation ("PARENT"), MARISUB, INC., a Delaware corporation and the wholly-owned...Stock Purchase Agreement • March 16th, 1998 • Watson Pharmaceuticals Inc • Pharmaceutical preparations
1 Exhibit 1.1 WATSON PHARMACEUTICALS, INC. 7 1/8% SENIOR NOTES DUE 2008 UNDERWRITING AGREEMENTUnderwriting Agreement • May 18th, 1998 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • New York
ANDCredit Agreement • March 16th, 1998 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • California
EXHIBIT 10.4 STANDARD COMMERCIAL LEASED ----------------------- (EXISTING BUILDING) 3400 W. Lake Avenue IL 1/80 ----------------------- Drafted January 4, 1984 ----------------------- LEASE AGREEMENTLease Agreement • March 31st, 1999 • Watson Pharmaceuticals Inc • Pharmaceutical preparations
AMONGAsset Purchase Agreement • October 31st, 1997 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • Illinois
WATSON PHARMACEUTICALS, INC. 10,537,755 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • November 17th, 2010 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • New York
Quiver Inc., a British Virgin Islands limited liability company and a stockholder (the “Selling Stockholder”) of Watson Pharmaceuticals, Inc., a Nevada corporation (the “Company”), proposes to sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), 10,537,755 shares of common stock, par value $0.0033 per share, of the Company (the “Shares”). To the extent there are no additional Underwriters listed on Schedule 1 hereto other than you, the term Representative as used herein shall mean you, as Underwriter, and the term Underwriters shall mean either the singular or plural as the context requires. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
EXHIBIT 10.10 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (the "Agreement") dated as of July 27, 1998 by and between Michael E. Boxer ("Employee") and Watson Pharmaceuticals, Inc. ("Company"). In consideration of the mutual covenants contained in...Employment Agreement • March 31st, 1999 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • California
CREDIT AGREEMENT WATSON PHARMACEUTICALS, INC. and MELLON BANK, N.A. February 3, 1999Credit Agreement • March 31st, 1999 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • California
WITNESSETH ----------Distribution Agreement • March 30th, 2001 • Watson Pharmaceuticals Inc • Pharmaceutical preparations
5 2 1.3. Effective Time. If all the conditions to the Merger set forth in Article VI of this Agreement have been fulfilled or waived and this Agreement shall not have been terminated as provided in Article VII hereof, the parties hereto shall cause a...Merger Agreement • January 9th, 1997 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • Florida
1 EXHIBIT 10.27 CONFIDENTIAL TREATMENT - NOTED BY * AND STRIKE-THROUGH STOCK PURCHASE AGREEMENT THIS AGREEMENT is made as of August 25, 1997, among Hoechst Marion Roussel, Inc., a Delaware corporation ("Parent"), Marisub, Inc., a Delaware corporation...Stock Purchase Agreement • May 5th, 1998 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • New York
1 EXHIBIT 8.1 February 20, 1997 Board of Directors Watson Pharmaceuticals, Inc. 311 Bonnie Circle Corona, CA 91720 Re: Agreement and Plan of Merger By and Among Watson Pharmaceuticals, Inc., Dolphins Acquisition Corp., and Royce Laboratories, Inc....Merger Agreement • February 21st, 1997 • Watson Pharmaceuticals Inc • Pharmaceutical preparations
1 Exhibit 10.1 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (the "Agreement") dated as of ________ ___, 1996 by and between Glenn A. Oclassen ("Employee"), Oclassen Pharmaceuticals, Inc., a Delaware corporation ("Company") and Watson...Employment Agreement • November 18th, 1996 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • California
RECITAL:Consulting Agreement • March 16th, 1998 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • Florida
December 6, 2001 By Federal Express Re: Watson Pharmaceuticals, Inc. ---------------------------- To the Parties listed on Annex A hereto: Societe Generale, Watson Pharmaceuticals, Inc. and Wachovia Bank N.A. ("Wachovia") have agreed that Societe...Amended and Restated Credit Agreement • April 1st, 2002 • Watson Pharmaceuticals Inc • Pharmaceutical preparations
Societe Generale, Watson Pharmaceuticals, Inc. and Wachovia Bank N.A. ("Wachovia") have agreed that Societe Generale will resign as administrative agent under the Amended and Restated Credit Agreement dated as of August 28, 2000 (the "Agreement") among Watson Pharmaceuticals, Inc., the Lenders, SG Cowen Securities Corporation, Societe Generale, First Union National Bank and Summit Bank, and Wachovia will succeed Societe Generale as administrative agent under such Agreement. The transition from Societe Generale to Wachovia as administrative agent under the Agreement will occur over the next thirty (30) days and will be an orderly transition.
Exhibit 10.13 [*] Confidential treatment requested MANUFACTURING AND SUPPLY AGREEMENT MANUFACTURING AND SUPPLY AGREEMENT ("Agreement") dated as of December 1, 1998 ("Effective Date"), between Makoff R&D Laboratories, Inc. with offices at 4640...Manufacturing and Supply Agreement • March 30th, 2001 • Watson Pharmaceuticals Inc • Pharmaceutical preparations
CONFIDENTIAL TREATMENT - NOTED BY * AND STRIKE-THROUGH *Contract Manufacturing Agreement • May 6th, 1998 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • New York
SECOND AMENDMENT TO STOCK PURCHASE AGREEMENTStock Purchase Agreement • May 5th, 1998 • Watson Pharmaceuticals Inc • Pharmaceutical preparations
Exhibit 10.14 [*] Confidential treatment requested TRADEMARK AGREEMENT TRADEMARK AGREEMENT dated this 26th day of August 1993, by and between RHONE- POULENC RORER GMBH, a German company with offices at Nattermannallee 3, 50829 Cologne, Germany, A....Trademark Agreement • March 30th, 2001 • Watson Pharmaceuticals Inc • Pharmaceutical preparations
March 11,1997 Dr. Melvin Sharoky c/o Somerset Pharmaceuticals, Inc. P.O. Box 30706 Tampa, Florida 33630 Re: Continued Employment Dear Dr. Sharoky: This letter confirms our discussions regarding your continued employment pursuant to the Employment...Employment Agreement • March 31st, 1997 • Watson Pharmaceuticals Inc • Pharmaceutical preparations
RECITALSBusiness Loan Agreement • March 31st, 1997 • Watson Pharmaceuticals Inc • Pharmaceutical preparations
CONFIDENTIAL TREATMENT - NOTED BY * AND STRIKE-THROUGH *Supply and License Agreement • May 5th, 1998 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • New York
